Tamio Okimoto

6PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersEpidemiological modellingHuman biophysicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2026
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective Validation.

|May 04, 2026
A Predicted FEV1/FVC Model Based on a Simple Respiratory Questionnaire for Early Diagnosis of COPD in Shimane Cohort, Japan.

|Dec 11, 2025
Bronchial Physiological Saline Injection to Visualize Peripheral Pulmonary Lesions in Ultrathin Bronchoscopy.

Mika Nakao, Tamio Okimoto, Noriaki Kurimoto

|Aug 29, 2024
Therapeutic Senolysis of Axitinib-Induced Senescent Human Lung Cancer Cells.

Hitoshi Kotani, Wei Han, Yuichi Iida

|Apr 13, 2023
An 83-year-old patient with RET fusion-positive non-small cell lung cancer experiencing severe hepatic disorder due to selpercatinib administration.

Kazuhisa Nakashima, Yuki Mitarai, Seiko Tanaka

|May 26, 2018
Pleuroparenchymal fibroelastosis after haematopoietic stem cell transplantation without graft-versus-host disease findings.

Tamio Okimoto, Yukari Tsubata, Megumi Hamaguchi

Pageof 1

Frequent Collaborators

2 joint publications

Yukari Tsubata

2 joint publications

Ryosuke Tanino

2 joint publications

Takamasa Hotta

1 joint publications

Kazuhisa Nakashima